# Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia

> **NCT00630565** · PHASE2,PHASE3 · TERMINATED · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 12 (actual)

## Conditions studied

- Leukemia

## Interventions

- **BIOLOGICAL:** sargramostim
- **DRUG:** busulfan
- **DRUG:** cyclophosphamide
- **DRUG:** dexamethasone
- **DRUG:** etoposide
- **PROCEDURE:** bone marrow transplantation
- **PROCEDURE:** hematopoietic stem cell transplantation
- **PROCEDURE:** peripheral blood stem cell transplantation
- **RADIATION:** total-body irradiation

## Key facts

- **NCT ID:** NCT00630565
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-07-26
- **Primary completion:** 2022-07-28
- **Final completion:** 2022-07-28
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Slow Accrual
- **Last updated:** 2024-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00630565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00630565, "Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT00630565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*